string(66) "/publication/xadago-slows-evenamide-lags-but-stars-ahead/25236
" string(63) "/publication/golden-opportunities-for-contrarian-fund/25192
" string(52) "/publication/investing-for-future-growth-2/25194
" string(66) "/publication/continued-strong-like-for-like-sales-growth/25202
" string(62) "/publication/h119-results-fyb201-fda-filing-imminent/25211
" string(44) "/publication/entering-harvest-mode/25214
" string(48) "/publication/is-this-the-turning-point/25200
" string(52) "/publication/portfolio-progress-continuing/25199
" string(60) "/publication/valuation-us27-58-potential-32-upside/25216
" string(59) "/publication/market-share-gains-but-no-h2-pick-up/25191
" string(44) "/publication/a-new-wave-of-lending/25237
" string(45) "/publication/all-divisions-on-track/25207
" string(56) "/publication/accelerating-investment-in-growth/25221
" string(64) "/publication/golden-opportunities-for-contrarian-fund/25192/
" string(56) "/publication/backbone-of-the-energy-revolution/25233
" string(55) "/publication/genesis-of-a-golden-opportunity/25134/
" string(59) "/publication/adding-accounts-and-firmly-in-profit/25213
" string(58) "/publication/weak-evaporator-market-affects-h119/25218
" string(66) "/publication/new-strategic-plan-new-sales-expected-fy20/25166/
" string(57) "/publication/accelerating-investment-in-growth/25221/
" string(49) "/publication/is-this-the-turning-point/25200/
" string(61) "/publication/valuation-us27-58-potential-32-upside/25216/
" string(57) "/publication/harry-peers-deal-enhances-earnings/25235
" string(67) "/publication/continued-strong-like-for-like-sales-growth/25202/
" string(66) "/publication/boosting-organic-growth-with-us-acquisition/24804
" string(62) "/publication/revenues-more-than-doubled-during-fy18/23600/
" string(64) "/publication/leveraging-financial-strength-to-grow-aam/25201
" string(72) "/publication/progress-towards-full-implementation-of-strategy/25176/
" string(53) "/publication/fuelling-the-hydrogen-economy/25046/
" string(34) "/publication/tough-going/25212
" string(59) "/publication/weak-evaporator-market-affects-h119/25218/
" string(63) "/publication/h119-results-fyb201-fda-filing-imminent/25211/
" string(65) "/publication/leveraging-financial-strength-to-grow-aam/25201/
" string(60) "/publication/market-share-gains-but-no-h2-pick-up/25191/
" string(45) "/publication/entering-harvest-mode/25214/
" string(67) "/publication/tg4001-first-efficacy-data-presented-at-esmo/25234
" string(64) "/publication/non-core-disposal-further-reduces-gearing/25037
" string(53) "/publication/portfolio-progress-continuing/25199/
" string(72) "/publication/progress-in-heart-failure-and-controlled-release/24401/
" string(53) "/publication/investing-for-future-growth-2/25194/
" string(60) "/publication/adding-accounts-and-firmly-in-profit/25213/
" string(64) "/publication/product-innovation-supports-order-growth/25185/
" string(36) "/publication/dutch-delight/25188
" string(37) "/publication/dutch-delight/25188/
" string(45) "/publication/a-new-wave-of-lending/25237/
" string(48) "/publication/advantage-growth-resumes/25180/
" string(46) "/publication/all-divisions-on-track/25207/
" string(70) "/publication/rd-progress-triggers-milestone-payment-windfall/25190
" string(52) "/publication/fuelling-the-hydrogen-economy/25046
" string(71) "/publication/progress-towards-full-implementation-of-strategy/25176
" string(37) "/publication/zesty-outlook/24538/
" string(58) "/publication/harry-peers-deal-enhances-earnings/25235/
" string(65) "/publication/interim-phase-ii-clepsidra-results-at-esmo/25189
" string(65) "/publication/new-ceo-as-company-moves-toward-late-stage/25059
" string(65) "/publication/new-strategic-plan-new-sales-expected-fy20/25166
" string(39) "/publication/strong-pipeline/24151/
" string(67) "/publication/boosting-organic-growth-with-us-acquisition/24804/
" string(67) "/publication/xadago-slows-evenamide-lags-but-stars-ahead/25236/
" string(69) "/publication/growing-portfolio-dividends-and-social-impact/24469/
" string(57) "/publication/backbone-of-the-energy-revolution/25233/
" string(32) "/publication/going-up/25187/
" string(68) "/publication/tg4001-first-efficacy-data-presented-at-esmo/25234/
" string(64) "/publication/third-consecutive-year-of-record-results/24760/
" string(35) "/publication/tough-going/25212/
" string(51) "/publication/8m-raise-to-drive-expansion/21655/
" string(47) "/publication/advantage-growth-resumes/25180
" string(55) "/publication/exciting-opportunities-emerging/25173/
" string(66) "/publication/interim-phase-ii-clepsidra-results-at-esmo/25189/
" string(55) "/publication/new-debt-investment-in-optinose/25184/
" string(52) "/publication/reiterating-outlook-for-fy19/25027/
" string(71) "/publication/successful-large-share-issue-transforms-outlook/24497/
" string(63) "/publication/major-customer-not-moving-to-production/24465/
" string(59) "/publication/opportunity-amid-uk-market-weakness/25107/
" string(63) "/publication/product-innovation-supports-order-growth/25185
" string(56) "/publication/steady-progress-with-core-assets/25049/
" string(70) "/publication/continuing-to-benefit-from-strong-fundamentals/25031/
" string(71) "/publication/rd-progress-triggers-milestone-payment-windfall/25190/
" string(56) "/publication/cash-flow-miner-growth-generator/23936/
" string(60) "/publication/ce-marks-for-actiste-device-received/24976/
" string(65) "/publication/coloured-gemstones-outperforming-diamonds/25162/
" string(36) "/publication/on-a-mission/23904/
" string(56) "/publication/restructured-with-new-leadership/24639/
" string(67) "/publication/sale-of-hawkeye-360-returns-to-shareholders/25140/
" string(59) "/publication/visible-income-and-growth-potential/25062/
" string(59) "/publication/continued-project-portfolio-ramp-up/25164/
" string(54) "/publication/exciting-opportunities-emerging/25173
" string(60) "/publication/inm-755-getting-closer-to-the-clinic/25156/
" string(65) "/publication/non-core-disposal-further-reduces-gearing/25037/
" string(66) "/publication/preparing-for-dnv3837-phase-ii-trial-start/24007/
" string(70) "/publication/stronger-nav-returns-but-discount-remains-wide/24842/
" string(58) "/publication/a-closer-look-at-german-regulation/25019/
" string(48) "/publication/another-good-performance/24903/
" string(41) "/publication/confident-outlook/23914/
" string(70) "/publication/finding-opportunities-away-from-the-mainstream/24603/
" string(64) "/publication/fragility-of-supply-demand-picture-to-continue/
" string(69) "/publication/harlex-acquisition-boosts-snps-presence-in-uk/17181/
" string(61) "/publication/in-a-cell-and-gene-therapy-sweet-spot/24313/
" string(59) "/publication/inm-755-getting-closer-to-the-clinic/25156
" string(62) "/publication/major-customer-not-moving-to-production/24465
" string(48) "/publication/mgc-derma-sale-completed/23542/
" string(60) "/publication/strategic-review-of-asset-management/25014/
" string(58) "/publication/visible-income-and-growth-potential/25062
" string(52) "/publication/a-productive-and-active-h119/25186/
" string(47) "/publication/a-year-of-data-readouts/23519/
" string(69) "/publication/diversified-biotech-championing-antibiotics-2/23652/
" string(60) "/publication/extending-the-earnings-growth-record/24526/
" string(55) "/publication/first-vafidemstat-efficacy-data/24029/
" string(68) "/publication/fy18-results-fyb201-launch-on-track-for-2021/24222/
" string(31) "/publication/going-up/25187
" string(66) "/publication/innovation-in-environmental-sustainability/22340/
" string(67) "/publication/long-established-emerging-markets-expertise/24125/
" string(54) "/publication/new-debt-investment-in-optinose/25184
" string(51) "/publication/oil-established-in-block-xx/25167/
" string(35) "/publication/on-a-mission/8447/
" string(43) "/publication/onwards-and-upwards/24840/
" string(67) "/publication/power-gas-the-growth-engine-of-mytilineos-2/24661/
" string(51) "/publication/streamlining-its-operations/25175/
" string(46) "/publication/strong-medical-support/24221/
" string(67) "/publication/a-growing-stockbroker-and-corporate-adviser/15339/
" string(57) "/publication/burgeoning-bioprocessing-revenues/24966/
" string(65) "/publication/capital-raised-for-accretive-acquisitions/24806/
" string(48) "/publication/clyra-gets-510k-clearance/25161
" string(64) "/publication/filed-for-approval-in-us-japan-and-china/24152/
" string(61) "/publication/full-year-results-and-clinical-updates/25177
" string(65) "/publication/initial-cannepil-purchase-orders-received/24577/
" string(58) "/publication/lincoln-crestal-positive-flow-test/25043/
" string(70) "/publication/more-than-just-the-vegan-friendly-sausage-roll/24772/
" string(68) "/publication/pre-ipo-focused-natural-resources-specialist/24453/
" string(75) "/publication/private-public-healthcare-fund-continues-to-deliver/24781/
" string(51) "/publication/scaling-regional-powerhouse/24555/
" string(41) "/publication/strong-pipeline-2/24853/
" string(46) "/publication/2019-finishes-strongly/24355/
" string(64) "/publication/2019-mongolia-drilling-campaign-kick-off/24601/
" string(52) "/publication/a-closer-look-at-german-regulation/
" string(51) "/publication/a-productive-and-active-h119/25186
" string(66) "/publication/a-wealth-of-asset-management-opportunities/24610/
" string(60) "/publication/aiming-for-consistent-outperformance/24707/
" string(58) "/publication/attractive-long-term-total-returns/24922/
" string(56) "/publication/barhemsys-round-three-pdufa-date/25163/
" string(68) "/publication/biosimilar-focus-after-successful-partnering/22774/
" string(43) "/publication/by-leaps-and-bounds/24612/
" string(52) "/publication/corporate-split-going-to-plan/25118
" string(32) "/publication/dazzling/23877/
" string(40) "/publication/destiny-beguiles/21913/
" string(39) "/publication/dno-norway-jose/22158/
" string(66) "/publication/ebitda-milestone-achieved-hull-build-delay/23987/
" string(71) "/publication/exposure-to-niche-attractively-valued-companies/24249/
" string(71) "/publication/following-a-well-established-investment-process/23769/
" string(50) "/publication/growth-strategy-paying-off/24161/
" string(64) "/publication/guidance-odor-no-more-break-even-by-ye19/23858/
" string(68) "/publication/higher-capacity-at-8-8mtpa-lower-spa-pricing/24366/
" string(46) "/publication/innovation-at-its-core/22051/
" string(65) "/publication/kicking-the-hornets-nest-of-immunoncology/21292/
" string(47) "/publication/mobile-commerce-enabler/23768/
" string(70) "/publication/perfect-storm-as-sales-stall-forecasts-revised/24889/
" string(53) "/publication/potential-delay-to-nootkatone/23736/
" string(65) "/publication/progressing-towards-proof-of-concept-data/23583/
" string(34) "/publication/q3-in-line/24654/
" string(50) "/publication/solid-push-towards-year-end/24431
" string(57) "/publication/stopping-metastasis-in-its-tracks/24256/
" string(50) "/publication/streamlining-its-operations/25175
" string(47) "/publication/strong-year-in-progress/24937/
" string(58) "/publication/weakness-in-grosvenor-affects-ebit/20780/
" string(50) "/publication/2019-year-of-the-peppa-pig/22709/
" string(45) "/publication/8m-raise-to-drive-expansion/
" string(65) "/publication/a-specialist-tech-investor-in-the-buyout-market/
" string(71) "/publication/a-specialist-tech-investor-in-the-buyout-market/24304/
" string(59) "/publication/an-innovative-play-on-the-app-market/6461/
" string(34) "/publication/brakes-off/22267/
" string(58) "/publication/brighter-prospects-in-latin-america/8339/
" string(69) "/publication/building-a-pipeline-of-third-wave-biosimilars/18752/
" string(37) "/publication/building-well/22288/
" string(59) "/publication/ce-marks-for-actiste-device-received/24976
" string(47) "/publication/challenges-on-the-track/25132/
" string(50) "/publication/consistent-cash-generation/23592/
" string(47) "/publication/continued-growth-in-aum/24845/
" string(57) "/publication/continuing-positive-returns-in-q4/24866/
" string(70) "/publication/defensive-positioning-and-solid-dividend-cover/24797/
" string(68) "/publication/deposit-solutions-becoming-a-fintech-unicorn/25112/
" string(68) "/publication/diversified-biotech-championing-antibiotics-2/23652
" string(41) "/publication/eha-data-released/24457/
" string(64) "/publication/enoxaparin-biosimilars-natural-evolution/19056/
" string(51) "/publication/evolving-the-business-model/25057/
" string(50) "/publication/exclusivity-pays-dividends/23533/
" string(67) "/publication/execution-of-virginia-stage-one-development/24485/
" string(42) "/publication/expanding-pipeline/25174/
" string(65) "/publication/exploiting-a-niche-in-uk-real-estate-debt/22642/
" string(46) "/publication/eyes-focused-on-evofem/24846/
" string(65) "/publication/finding-attractively-priced-opportunities/23555/
" string(71) "/publication/finding-high-yields-and-dividend-growth-in-asia/24348/
" string(69) "/publication/focus-on-us-fix-ahead-of-setting-a-new-agenda/24912/
" string(69) "/publication/folfirinox-sets-bar-in-pancreatic-cancer-high/21343/
" string(63) "/publication/four-exploration-wells-planned-for-2019/23264/
" string(65) "/publication/fruquintinib-fresco-meets-its-primary-endpoints/
" string(49) "/publication/further-progress-in-china/24971/
" string(54) "/publication/genesis-of-a-golden-opportunity/25134
" string(36) "/publication/h119-results/25154/
" string(70) "/publication/impact-of-huawei-ban-is-limited-and-short-term/24250/
" string(55) "/publication/incubating-innovation-in-iodine/22197/
" string(65) "/publication/innovation-in-environmental-sustainability/22340
" string(70) "/publication/investor-day-confirms-structural-growth-trends/24235/
" string(53) "/publication/launches-continue-to-progress/18007/
" string(61) "/publication/long-established-expertise-in-vietnam/24201/
" string(68) "/publication/low-cost-high-impact-onshore-oil-exploration/21491/
" string(62) "/publication/management-raises-fy20-profit-guidance/25012/
" string(69) "/publication/managers-bullish-on-healthcare-sector-outlook/24382/
" string(59) "/publication/market-heavily-discounting-sea-lion/23224/
" string(66) "/publication/mature-us-onshore-production-consolidation/22169/
" string(68) "/publication/mbe-deliveries-offset-lower-evaporator-sales/24800/
" string(67) "/publication/mobile-payment-platform-for-digital-content/20200/
" string(69) "/publication/more-than-just-the-vegan-friendly-sausage-roll/24772
" string(53) "/publication/oil-established-in-block-xx/25167/l/
" string(66) "/publication/outperforming-its-benchmark-and-peer-group/24429/
" string(48) "/publication/outperforming-the-market/24748/
" string(59) "/publication/phocus-turns-to-earlier-stage-assets/25130
" string(60) "/publication/photonics-driving-second-growth-wave/19560/
" string(52) "/publication/pipeline-and-margin-momentum/17753/
" string(52) "/publication/portfolio-rebased-for-growth/23501/
" string(43) "/publication/premium-positioning/23832/
" string(50) "/publication/record-production-achieved/25064/
" string(71) "/publication/results-in-line-and-strategic-plan-taking-shape/24515/
" string(68) "/publication/robust-performance-while-delivering-strategy/24642/
" string(64) "/publication/south-disouq-first-gas-and-h219-drilling/23093/
" string(42) "/publication/space-to-manoeuvre/23616/
" string(61) "/publication/spartan-a-value-accretive-transaction/21038/
" string(56) "/publication/strength-through-diversification/24623/
" string(38) "/publication/test-123-11111123123/
" string(57) "/publication/tough-environment-easing-slightly/24984/
" string(55) "/publication/trading-ahead-of-expectations-2/25058/
" string(61) "/publication/us-prostate-cancer-study-progresses-2/24910/
" string(68) "/publication/valuation-remains-attractive-after-strong-q1/24358/
" string(55) "/publication/visible-long-term-income-growth/22190/
" string(63) "/publication/visit-to-the-kinsevere-copper-operation/16203/
" string(53) "/publication/waiting-for-the-roman-results/11610/
" string(64) "/publication/wipac-move-into-mid-volumes-under-review/24378/
" string(53) "/publication/0-9-1-7moz-exploration-target/24565/
" string(74) "/publication/achieving-superior-returns-from-alternative-assets/23895/
" string(54) "/publication/an-emerging-global-biopharma-2/24554/
" string(73) "/publication/another-beat-with-structural-and-cyclical-drivers/25028/
" string(46) "/publication/building-to-a-crescendo/25102
" string(64) "/publication/careful-resourcing-supportive-environment/25141
" string(61) "/publication/cash-generation-engine-powers-onwards/23972/
" string(72) "/publication/cbmg-and-novartis-sign-manufacturing-partnership/22220/
" string(58) "/publication/combination-trials-gather-momentum/15434/
" string(51) "/publication/data-driven-catalysts-ahead/24882/
" string(71) "/publication/differentiated-treatment-for-alzheimers-disease/23682/
" string(54) "/publication/diversifying-outside-argentina/25114/
" string(45) "/publication/doubling-down-on-oryx/25045/
" string(71) "/publication/emerging-markets-specialist-unloved-asset-class/22457/
" string(65) "/publication/enabling-electronic-devices-of-the-future/24260/
" string(49) "/publication/encouraging-h219-momentum/25077/
" string(66) "/publication/endoxifen-complements-atossas-cancer-focus/17607/
" string(41) "/publication/expanding-pipeline/25174
" string(67) "/publication/fcf-to-drive-growth-in-rli-and-cash-returns/24144/
" string(66) "/publication/fda-issues-ccp-07-complete-response-letter/18594/
" string(49) "/publication/firing-on-all-cylinders-6/24737/
" string(55) "/publication/first-510k-filed-with-the-fda-2/24191/
" string(69) "/publication/fragility-of-supply-demand-picture-to-continue/6564/
" string(51) "/publication/full-year-financial-results/23931/
" string(63) "/publication/full-year-results-and-clinical-updates/2 5177/
" string(48) "/publication/fully-fledged-ftse-250-2/24194/
" string(73) "/publication/fy19-in-line-with-our-recently-upgraded-forecasts/24340/
" string(64) "/publication/good-start-in-the-us-cerament-g-v-growth/23720/
" string(41) "/publication/growth-inflection-point/
" string(47) "/publication/growth-inflection-point/24909/
" string(60) "/publication/improving-ongoing-business-footprint/24087/
" string(55) "/publication/investing-in-special-situations/18524/
" string(66) "/publication/lancaster-eps-performing-above-expectations/24722
" string(67) "/publication/lancaster-eps-performing-above-expectations/24722/
" string(70) "/publication/long-term-record-of-double-digit-total-returns/24852/
" string(72) "/publication/maintained-expectations-awaiting-strategy-update/24811/
" string(38) "/publication/marching-on-up/23961/
" string(49) "/publication/mixed-results-in-block-xx/25088/
" string(61) "/publication/moving-towards-rd-inflection-points-2/23649/
" string(68) "/publication/multiple-partnerships-enable-diversification/24148/
" string(55) "/publication/multiple-studies-moving-forward/24386/
" string(67) "/publication/nav-and-forecast-update-south-disouq-delays/23958/
" string(65) "/publication/new-aum-allows-for-higher-management-fees/24983/
" string(73) "/publication/new-growth-plans-for-overseas-income-specialist-2/24203/
" string(50) "/publication/new-manager-motoring-ahead/24633/
" string(71) "/publication/new-products-and-cost-containment-drive-profits/25063/
" string(69) "/publication/perfect-storm-as-sales-stall-forecasts-revised/24889
" string(53) "/publication/phase-ii-xanadu-trial-results/24101/
" string(74) "/publication/price-competitive-generic-and-biosimilar-therapies/17942/
" string(67) "/publication/progressing-with-portfolio-expansion-agenda/24932/
" string(69) "/publication/purchase-of-3ms-ballistic-protection-business/24805/
" string(52) "/publication/q219-ffo-4-8-below-consensus/24710/
" string(36) "/publication/quantum-leap/18734/
" string(48) "/publication/reasons-to-be-optimistic/21684/
" string(54) "/publication/recommended-cash-offer-at-230p/25122/
" string(66) "/publication/resolution-cpr-published-ahead-of-farm-out/24002/
" string(49) "/publication/setting-its-sights-higher/25110/
" string(57) "/publication/short-term-value-long-term-growth/25108/
" string(64) "/publication/significant-licence-deal-with-us-biotech/17986/
" string(51) "/publication/solid-push-towards-year-end/24431/
" string(57) "/publication/south-african-lng-and-helium-play/20574/
" string(53) "/publication/streamlined-business-on-track/24634/
" string(65) "/publication/strong-h1-lays-foundations-for-transition/20576/
" string(45) "/publication/strong-medical-support/24221
" string(54) "/publication/surfing-the-next-wave-of-biosimilars/
" string(60) "/publication/talicia-launch-for-h-pylori-in-sight/24257/
" string(63) "/publication/the-opioid-use-disorder-patient-journey/23398/
" string(49) "/publication/time-for-better-treatment/22112/
" string(71) "/publication/trading-in-line-and-implementing-strategic-plan/25143/
" string(36) "/publication/trust-worthy/23947/
" string(58) "/publication/two-material-events-on-the-horizon/24789/
" string(71) "/publication/us-customer-supports-substantial-revenue-growth/23882/
" string(67) "/publication/us-nanotherm-ide-approval-a-major-milestone/20445/
" string(63) "/publication/us-sales-rebound-and-new-clinical-study/24407/
" string(37) "/publication/winning-wines/18062/
" string(64) "/publication/wipac-costs-higher-than-expected-in-q419/23980/
" string(69) "/publication/21-total-return-in-h1-continues-strong-growth/23179/
" string(56) "/publication/a-further-step-up-in-performance/24397/
" string(60) "/publication/a-new-chapter-with-location-sciences/20373/
" string(64) "/publication/a-productive-first-year-to-say-the-least/24790/
" string(65) "/publication/a-record-quarter-continued-high-dividends/23809/
" string(65) "/publication/a-strong-2018-for-the-commercial-business/24057/
" string(61) "/publication/accelerating-mobile-identity-offering/22929/
" string(65) "/publication/accumulating-data-for-nbtxr3-and-io-combo/17966/
" string(56) "/publication/acquisition-of-circle-oil-assets/17924/
" string(52) "/publication/adding-fibre-and-5g-capacity/21029/
" string(72) "/publication/affimer-potential-best-in-class-antibody-mimetic/24390/
" string(67) "/publication/aipac-phase-iib-starts-randomised-component/18027/
" string(52) "/publication/all-set-for-an-eventful-2019/23814/
" string(62) "/publication/an-exceptionally-strong-end-to-the-year/23108
" string(50) "/publication/awaiting-for-eventful-2019/21579/
" string(57) "/publication/base-support-services-for-oil-gas/16460/
" string(56) "/publication/battery-materials-driving-growth/25051/
" string(67) "/publication/beginning-to-implement-its-revised-strategy/24284/
" string(54) "/publication/biosimilar-enoxaparin-launches/19870/
" string(68) "/publication/boosting-organic-growth-with-us-acquisition /24804/
" string(59) "/publication/bringing-ai-to-the-treatment-of-oud/24873/
" string(58) "/publication/broad-based-strong-profit-growth-2/24210/
" string(70) "/publication/broader-capability-expands-the-opportunity-set/23661/
" string(73) "/publication/broadly-in-line-as-new-ceo-starts-in-mid-february/23280/
" string(55) "/publication/building-a-diversified-pipeline/16644/
" string(41) "/publication/building-strongly/24843/
" string(62) "/publication/cannabis-based-medicines-and-cosmetics/22376/
" string(65) "/publication/careful-resourcing-supportive-environment/25141/
" string(51) "/publication/clear-path-to-profitability/21952/
" string(58) "/publication/continued-project-portfolio-ramp-up/25164
" string(56) "/publication/continued-sector-diversification/25018/
" string(60) "/publication/continuing-dividend-growth-forecast-2/23651
" string(56) "/publication/continuing-positive-returns-in-q4/24866
" string(67) "/publication/correction-presents-long-term-opportunities/22655/
" string(56) "/publication/creating-value-from-stored-value/24416/
" string(67) "/publication/data-driven-diabetes-management-as-a-service/7575/
" string(51) "/publication/data-the-connecting-currency/24370
" string(52) "/publication/data-the-connecting-currency/24370/
" string(31) "/publication/dazzling/23877
" string(72) "/publication/disciplined-leveraged-loan-investment-specialist/23541/
" string(66) "/publication/diversified-exposure-to-pan-asian-equities/22502/
" string(47) "/publication/diversifying-asset-base/17308/
" string(67) "/publication/doria-phase-iii-trial-hits-primary-endpoint/23705/
" string(52) "/publication/doubling-down-on-the-winners/24021/
" string(65) "/publication/drilling-recovery-but-a-growing-debt-pile/24135/
" string(50) "/publication/ebitda-break-even-in-sight/17070/
" string(57) "/publication/encouraging-h1-but-all-eyes-on-h2/25120/
" string(60) "/publication/endoxifen-catalysts-expected-in-2019/24107/
" string(39) "/publication/entering-harvest-mode/
" string(70) "/publication/established-vehicle-with-new-engine-for-growth/23082/
" string(75) "/publication/european-small-cap-specialist-with-attractive-yield/20350/
" string(72) "/publication/expanding-on-a-proven-class-of-anti-cancer-drugs/19562/
" string(65) "/publication/fda-outcome-april-2020-ema-filing-in-q419/24847/
" string(60) "/publication/first-phase-ib-driiv-results-released/25111
" string(68) "/publication/focused-on-quality-income-and-capital-growth/25119/
" string(55) "/publication/forecast-and-valuation-upgraded/24061/
" string(62) "/publication/fundamentals-suggest-promising-outlook/22886/
" string(48) "/publication/further-progress-in-china/24971
" string(73) "/publication/fx-inflow-and-mix-changes-prompt-earnings-upgrade/24691/
" string(72) "/publication/fy19-in-line-with-our-recently-upgraded-forecasts/24340
" string(66) "/publication/fy19-prelims-after-a-momentous-second-half/24625/
" string(59) "/publication/gdc-0084-gets-a-fifth-collaboration/24977/
" string(39) "/publication/georgia-lake-pea/7865/
" string(26) "/publication/going-up/
" string(62) "/publication/good-potential-turnaround-well-advanced/21710
" string(36) "/publication/growing-fast/24122/
" string(51) "/publication/growth-and-profits-on-track/24329/
" string(57) "/publication/h119-results-fyb201-fda-filing-imminent/
" string(55) "/publication/hawkeye-360-piercing-the-clouds/24778/
" string(66) "/publication/high-yielding-fund-with-recovery-potential/24008/
" string(68) "/publication/imminent-return-to-free-cash-flow-generation/24985/
" string(53) "/publication/immunotherapy-research-engine/22913/
" string(47) "/publication/imo-2020-on-the-horizon/23735/
" string(59) "/publication/improving-outlook-expected-for-2019/24391/
" string(57) "/publication/innovative-orthobiologics-company/21394/
" string(43) "/publication/is-this-the-turning-point/
" string(50) "/publication/location-location-location/23015/
" string(63) "/publication/long-term-capital-growth-and-high-yield/24579/
" string(66) "/publication/making-good-progress-on-technology-roadmap/24973/
" string(41) "/publication/mammalian-movement/24028
" string(50) "/publication/margin-expansion-sustained/24898/
" string(53) "/publication/maritime-investment-solutions/19132/
" string(36) "/publication/mind-the-gap/24049/
" string(52) "/publication/more-growth-expected-in-h219/24962/
" string(68) "/publication/nanotherm-us-prostate-cancer-trial-initiates/21497/
" string(52) "/publication/new-dividend-policy-unveiled/17125/
" string(63) "/publication/new-name-same-tried-and-tested-approach/23860/
" string(70) "/publication/next-generation-of-dna-damage-repair-inhibitors/25072
" string(52) "/publication/ngal-test-hits-a-snag-at-fda/22254/
" string(69) "/publication/nu-q-lung-cancer-test-development-accelerates/24872/
" string(63) "/publication/odor-no-more-and-blest-almost-break-even/24979
" string(50) "/publication/oil-established-in-block-xx/25167
" string(52) "/publication/oil-established-in-block-xx/25167/l
" string(35) "/publication/on-a-mission/23904
" string(37) "/publication/on-the-cusp-2/25158/
" string(62) "/publication/on-track-for-expected-progress-in-fy20/24807/
" string(54) "/publication/on-track-for-filings-next-year/20658/
" string(58) "/publication/opportunity-amid-uk-market-weakness/25107
" string(63) "/publication/optimism-based-on-attractive-valuations/23380/
" string(55) "/publication/organic-arr-growth-rises-to-3-2/24767/
" string(60) "/publication/outsourcing-and-e-commerce-boosting-growth/
" string(60) "/publication/phocus-turns-to-earlier-stage-assets/25130/
" string(55) "/publication/pillars-of-growth-standing-firm/25106/
" string(52) "/publication/portfolio-clean-up-under-way/25075/
" string(69) "/publication/positive-performance-sets-platform-for-growth/19000/
" string(66) "/publication/powering-the-worlds-largest-electric-ferry/24860/
" string(68) "/publication/priming-immune-response-in-anticancer-combos/19847/
" string(68) "/publication/pro-forma-figures-10-5-eps-accretion-in-fy20/24426/
" string(53) "/publication/raising-fy19-forecasts-by-c-3/24822/
" string(66) "/publication/rapid-and-effective-diagnosis-of-infection/23942/
" string(62) "/publication/regulatory-progress-in-japan-and-the-us/25065
" string(63) "/publication/regulatory-progress-in-japan-and-the-us/25065/
" string(75) "/publication/return-to-dividend-paying-status-in-fy19-a-priority/22287/
" string(68) "/publication/revenue-guidance-is-cut-by-9-8-at-mid-points/21693/
" string(36) "/publication/rising-scale/20547/
" string(67) "/publication/robust-trading-performance-earnings-upgrade/24150/
" string(48) "/publication/sailing-against-the-wind/24997/
" string(50) "/publication/sales-pipeline-is-building/24281/
" string(63) "/publication/salt-plus-potash-plus-iron-equals-value/23373/
" string(69) "/publication/self-promotion-boost-to-strong-organic-growth/24725/
" string(54) "/publication/shell-announces-takeover-offer/24890/
" string(72) "/publication/significant-contribution-from-holding-in-aj-bell/24224/
" string(66) "/publication/significant-operational-improvements-in-h2/23374/
" string(41) "/publication/silence-is-golden/16753/
" string(66) "/publication/smartinhaler-improves-medication-adherence/16174/
" string(36) "/publication/space-to-grow/7185/
" string(38) "/publication/stable-outlook/24999/
" string(55) "/publication/steady-progress-with-core-assets/25049
" string(125) "/publication/steady-progress-with-core-assets/25049/?fbclid=IwAR2HYo7Gv_bWKZWeOjuJncm9qPt5SV_z5Mj5WJ2FKie8HFncqKR67oVHvpE
" string(125) "/publication/steady-progress-with-core-assets/25049/?fbclid=IwAR3t8xQ_O9r9RcWEAL8qdNj_KpYZFCk6QKAI2TCkIYAQatb91A54Xdksz8k
" string(66) "/publication/strategic-acquisition-using-cash-resources/24668/
" string(59) "/publication/strategic-review-of-asset-management/25014
" string(54) "/publication/strong-prospects-in-wound-care/15686/
" string(70) "/publication/successful-large-share-issue-transforms-outlook/24497
" string(62) "/publication/tackling-tumour-promoting-inflammation/21303/
" string(61) "/publication/taking-advantage-of-the-cannabis-boom/24288/
" string(48) "/publication/test-sales-up-43-in-h119/23077/
" string(50) "/publication/the-real-estate-optimisers/19145/
" string(49) "/publication/the-song-remains-the-same/22743/
" string(63) "/publication/third-consecutive-year-of-record-results/24760
" string(50) "/publication/thyroid-treatment-momentum/16755/
" string(37) "/publication/tipping-point/24809/
" string(58) "/publication/transitioning-to-commercialisation/24268/
" string(71) "/publication/transitioning-towards-sustainable-profitability/24568/
" string(61) "/publication/trials-on-track-as-cdnf-readout-nears/24938/
" string(32) "/publication/tuned-in/17034/
" string(57) "/publication/two-material-events-on-the-horizon/24789
" string(52) "/publication/two-new-cannabinoid-programs/19916/
" string(74) "/publication/value-orientated-portfolio-with-4-5-dividend-yield/24875/
" string(74) "/publication/widely-diversified-flexible-multi-asset-investment/24059/
" string(36) "/publication/zesty-outlook/24538
" string(290) "/translate_c?depth=1&hl=fr&prev=search&rurl=translate.google.ca&sl=en&sp=nmt4&u=https://www.edisongroup.com/publication/rd-progress-triggers-milestone-payment-windfall/25190/&xid=17259,15700023,15700186,15700190,15700256,15700259,15700262,15700265&usg=ALkJrhh4caONeqs2G0iKAAiwhznow1yIIg
" string(290) "/translate_c?depth=1&hl=fr&rurl=translate.google.fr&sl=auto&sp=nmt4&tl=fr&u=https://www.edisongroup.com/publication/boosting-organic-growth-with-us-acquisition/24804&xid=17259,15700023,15700186,15700190,15700256,15700259,15700262,15700265,15700270&usg=ALkJrhh-qPQGGD4sXDvtINczugmY-CDgmw
" string(61) "/publication/1-6m-deal-with-land-property-services/20742/
" string(132) "/publication/1-6m-deal-with-land-property-services/20742?preview_id=47180&preview_nonce=779de8972f&_thumbnail_id=-1&preview=true
" string(53) "/publication/10m-desalination-contract-win/24154/
" string(51) "/publication/8m-raise-to-drive-expansion/77777/
" string(71) "/publication/a-change-of-pace-with-three-new-clinical-trials/23974/
" string(57) "/publication/a-closer-look-at-german-regulation/25019
" string(59) "/publication/a-different-angle-on-an-old-problem/24897/
" string(70) "/publication/a-diversified-geographically-expanding-company/16416/
" string(37) "/publication/a-fresh-start/17999/
" string(50) "/publication/a-good-interim-performance/24243/
" string(51) "/publication/a-licensing-deal-for-cevira/24556/
" string(53) "/publication/a-licensing-deal-for-pascomer/24574/
" string(63) "/publication/a-new-regulatory-strategy-for-dovitinib/23893/
" string(44) "/publication/a-note-of-confidence/21370/
" string(47) "/publication/a-platform-for-growth-2/24229/
" string(36) "/publication/a-quieter-q2/24762/
" string(48) "/publication/a-refined-mediterranean-player/
" string(64) "/publication/a-robust-h119-for-trust-portfolio-and-ips/24679
" string(68) "/publication/a-robust-q1-despite-a-seasonally-weak-market/24093/
" string(54) "/publication/a-solid-first-half-performance/23701/
" string(70) "/publication/a-specialist-tech-investor-in-the-buyout-market/24304
" string(50) "/publication/a-strong-harvest-continues/21519/
" string(40) "/publication/a-strong-quarter/24252/
" string(45) "/publication/a-tough-environment-3/22742/
" string(60) "/publication/a-transformational-deal-with-newmont/21970/
" string(59) "/publication/a-transpacific-cell-therapy-company/18641/
" string(65) "/publication/a-wealth-of-asset-management-opportunities/24610
" string(49) "/publication/a-world-of-new-surfaces-2/18784/
" string(48) "/publication/a-year-of-solid-progress/17727/
" string(61) "/publication/acquisition-of-htis-plastics-division/19972/
" string(69) "/publication/adapting-to-a-new-global-healthcare-landscape/18894/
" string(62) "/publication/adapting-to-tougher-trading-conditions/24738/
" string(63) "/publication/adding-new-sales-channels-for-mydevices/21996/
" string(61) "/publication/adding-value-to-the-fintech-portfolio/24996/
" string(56) "/publication/adjusting-to-supply-chain-shifts/24941/
" string(71) "/publication/affimer-potential-best-in-class-antibody-mimetic/24390
" string(59) "/publication/aiming-for-consistent-outperformance/24707
" string(64) "/publication/aipac-fully-recruited-results-due-q120-2/24521/
" string(62) "/publication/aipac-fully-recruited-results-due-q120/24520/
" string(67) "/publication/aipac-phase-iib-starts-randomized-component/18039/
" string(39) "/publication/all-in-the-name/17052/
" string(51) "/publication/alternative-finance-company/15343/
" string(59) "/publication/amgen-offers-sek32-50-share-in-cash/24270/
" string(62) "/publication/an-advancing-immunotherapies-programme/16102/
" string(51) "/publication/an-emerging-global-biopharma/24551
" string(52) "/publication/an-emerging-global-biopharma/24551/
" string(63) "/publication/an-exceptionally-strong-end-to-the-year/23108/
" string(69) "/publication/an-unrivalled-video-game-outsourcing-offering/16105/
" string(56) "/publication/another-buyout-of-related-assets/24769/
" string(70) "/publication/asian-small-cap-specialist-unloved-asset-class/22760/
" string(68) "/publication/astute-deal-gives-key-project-a-path-to-production/
" string(68) "/publication/asx-listing-expected-as-funding-is-confirmed/23070/
" string(64) "/publication/atm-prudence-and-debt-management-actions/24054/
" string(57) "/publication/attractive-long-term-total-returns/24922
" string(63) "/publication/back-on-top-after-small-cap-renaissance/15511/
" string(62) "/publication/back-on-track-as-pivotal-study-resumes/19329/
" string(57) "/publication/balancing-risk-to-optimise-reward/17297/
" string(55) "/publication/barhemsys-round-three-pdufa-date/25163
" string(62) "/publication/becat-roll-out-benefits-top-line-growth/24131
" string(41) "/publication/better-visibility/23891/
" string(38) "/publication/big-in-japan-3/16224/
" string(67) "/publication/biosimilar-focus-after-successful-partnering/22774
" string(76) "/publication/biosimilar-focus-with-phase-iii-trial-about-to-start/23553/
" string(58) "/publication/bold-entry-into-the-us-marketplace/18614/
" string(61) "/publication/boosting-organic-growth-with-us-acquisition/
" string(40) "/publication/bouncing-signals/15771/
" string(36) "/publication/boxing-clever/23238
" string(37) "/publication/boxing-clever/23238/
" string(61) "/publication/brand-transformation-rolls-out-cash-2/23647/
" string(42) "/publication/branding-awareness/22484/
" string(66) "/publication/building-a-platform-for-sustainable-growth/22387/
" string(60) "/publication/building-an-emerging-markets-business/19365
" string(47) "/publication/building-to-a-crescendo/25102/
" string(56) "/publication/burgeoning-bioprocessing-revenues/24966
" string(65) "/publication/buyback-significantly-reduces-share-count/23779/
" string(65) "/publication/canfour-interim-phase-i-presented-at-esmo/22459/
" string(71) "/publication/capital-growth-and-above-average-dividend-yield/22163/
" string(60) "/publication/capital-growth-with-attractive-yield/21387/
" string(64) "/publication/capital-markets-day-cmd-breadth-of-value/24347/
" string(66) "/publication/capital-recycling-generating-strong-returns/8009/
" string(63) "/publication/capitalizing-on-age-related-eye-diseases/25153
" string(44) "/publication/case-for-the-defence/17179/
" string(52) "/publication/cash-flow-generation-at-mt-cattlin/
" string(55) "/publication/cash-flow-miner-growth-generator/23936
" string(60) "/publication/cash-generation-engine-powers-onwards/23972
" string(60) "/publication/cashed-up-and-hungry-for-investments/23405/
" string(65) "/publication/cavatak-yervoy-combo-enters-the-spotlight/18566/
" string(65) "/publication/cgi-to-acquire-scisys-for-254-15p-in-cash/24409/
" string(71) "/publication/change-in-strategy-driven-by-high-nugget-effect/23467/
" string(61) "/publication/chemetics-proof-is-in-the-deal-making/18040/
" string(55) "/publication/chinese-progress-and-us-lawyers/23698/
" string(51) "/publication/chp-taken-to-the-next-level/19028/
" string(62) "/publication/clarifying-position-on-turkish-exposure/18867
" string(63) "/publication/clarifying-position-on-turkish-exposure/18867/
" string(67) "/publication/cohort-2-starts-in-oncos-102-melanoma-trial/23621/
" string(65) "/publication/collaboration-and-supply-agreement-signed/22652/
" string(64) "/publication/coloured-gemstones-outperforming-diamonds/25162
" string(71) "/publication/commercial-progress-offsets-other-areas-in-fy19/24297/
" string(50) "/publication/commercialisation-on-track/21773/
" string(76) "/publication/concentrated-portfolio-offering-true-differentiation/24418/
" string(40) "/publication/confident-outlook/23914
" string(67) "/publication/continuing-to-find-attractive-opportunities/23267/
" string(61) "/publication/contract-extension-with-major-partner/23251/
" string(70) "/publication/contracts-for-feedstock-supply-and-power-sales/24207/
" string(53) "/publication/core-business-order-shortfall/23049/
" string(64) "/publication/cornerstone-components-with-quality-edge/19048/
" string(74) "/publication/cost-discipline-and-franchise-strength-in-evidence/24115/
" string(41) "/publication/craziness-averted/23033/
" string(60) "/publication/creative-business-partner-for-brands/25148/
" string(68) "/publication/cumulative-fcf-c8-7bn-in-the-next-five-years/25020/
" string(58) "/publication/debt-and-equity-investment-in-bdsi/24303/
" string(66) "/publication/debt-refinancing-provides-more-flexibility/24069/
" string(58) "/publication/deep-discount-and-attractive-yield/22564/
" string(56) "/publication/delivering-growth-in-mobile-engagement/
" string(60) "/publication/developing-both-as-asset-manager-and-owner/
" string(70) "/publication/differentiated-treatment-for-alzheimers-disease/23682
" string(123) "/publication/differentiated-treatment-for-alzheimers-disease/23682/?amp;utm_medium=EQS_pr&utm_campaign=ACW_18032019
" string(54) "/publication/disciplined-investment-process/23773/
" string(53) "/publication/disciplined-investment-process/8579/
" string(70) "/publication/discoveries-made-exploration-concept-validated/23041/
" string(43) "/publication/disposal-of-adintel/20402/
" string(52) "/publication/disposing-civita-makes-sense/19009/
" string(68) "/publication/disruptive-printed-circuit-board-prototyping/17014/
" string(72) "/publication/diversified-global-portfolio-with-high-dividends/20779/
" string(65) "/publication/diversified-strategy-showing-its-strength/22565/
" string(53) "/publication/diversifying-outside-argentina/25114
" string(49) "/publication/dominant-bowland-shale-position/
" string(56) "/publication/double-digit-order-growth-for-dm/21656/
" string(44) "/publication/doubling-down-on-oryx/25045
" string(71) "/publication/driving-share-gains-with-expanded-product-range/23559/
" string(31) "/publication/dutch-delight/
" string(61) "/publication/earnings-deferred-to-unlock-potential/24163/
" string(64) "/publication/earnings-growth-despite-market-headwinds/24032/
" string(65) "/publication/ebitda-milestone-achieved-hull-build-delay/23987
" string(64) "/publication/enabling-electronic-devices-of-the-future/24260
" string(51) "/publication/entering-a-new-growth-phase/18588/
" string(46) "/publication/entertainment-enhancer/24595/
" string(68) "/publication/established-on-the-ground-expertise-in-japan/22035/
" string(71) "/publication/established-vietnamese-equity-market-specialist/19300/
" string(39) "/publication/europe-starts-to-sing/
" string(50) "/publication/evenamide-down-but-not-out/24289/
" string(44) "/publication/everything-eversweet/22591/
" string(45) "/publication/evolving-the-business/21097/
" string(47) "/publication/evomela-launch-underway/24914/
" string(71) "/publication/exciting-car-opportunities-multiple-indications/18123/
" string(66) "/publication/execution-of-virginia-stage-one-development/24485
" string(50) "/publication/exit-from-canada-announced/24422/
" string(45) "/publication/exosomes-rise-further/21597/
" string(48) "/publication/expanding-eidv-in-the-us/23409/
" string(59) "/publication/extending-the-earnings-growth-record/24526
" string(46) "/publication/extra-quality-services/19441/
" string(45) "/publication/eyes-focused-on-evofem/24846
" string(68) "/publication/fast-and-objective-cervical-cancer-screening/22888/
" string(41) "/publication/fast-moving-focus/15908/
" string(52) "/publication/favourable-market-dynamics-2/23653/
" string(69) "/publication/fda-approval-attained-sales-execution-now-key/24700/
" string(65) "/publication/federated-wireless-51m-series-c-financing/24967/
" string(59) "/publication/fibreless-optical-links-in-the-skies/6304/
" string(43) "/publication/fighting-its-corner/25042/
" string(72) "/publication/finding-attractively-valued-growth-opportunities/24010/
" string(61) "/publication/finding-small-cap-value-opportunities/24417/
" string(58) "/publication/finding-value-in-out-of-favour-uk-stocks/
" string(79) "/publication/first-patient-implanted-with-iris-ii-retinal-prosthesis/15903/
" string(60) "/publication/first-thoughts-spirit-energy-farm-in/21897/
" string(51) "/publication/focus-on-delivery-and-growth/19295
" string(68) "/publication/focus-on-regional-commercial-property-income/16759/
" string(73) "/publication/focus-shifting-to-drilling-ahead-of-eps-first-oil/23856/
" string(67) "/publication/focused-on-quality-income-and-capital-growth/25119
" string(44) "/publication/fortified-for-growth/23457/
" string(33) "/publication/fraedom-to-grow/
" string(63) "/publication/fresh-preclinical-ory-2001-data-ory-1001-next/
" string(49) "/publication/from-strength-to-strength/19523/
" string(57) "/publication/full-year-results-give-confidence/23240/
" string(67) "/publication/funded-to-execute-phase-iib-study-as-planned/25098
" string(68) "/publication/funded-to-execute-phase-iib-study-as-planned/25098/
" string(64) "/publication/funding-solution-could-drive-fid-in-2018/19602/
" string(54) "/publication/funding-to-accelerate-uk-growth/24844
" string(62) "/publication/fy18-results-confirm-positive-momentum/22231/
" string(50) "/publication/fy19-off-to-a-strong-start/24335/
" string(60) "/publication/fy19-record-for-revenues-and-profits/24567/
" string(46) "/publication/german-edi-acquisition/17350/
" string(38) "/publication/getting-sweeter/6177/
" string(70) "/publication/global-opportunities-with-new-6-dividend-policy/21363
" string(37) "/publication/going-for-gold/16938
" string(72) "/publication/golden-age-for-lentivector-as-axovant-signs-deal/21307/
" string(69) "/publication/good-balanced-uk-trading-india-orders-growing/21931/
" string(44) "/publication/good-reasons-to-krow/23215/
" string(69) "/publication/greater-med-assets-provide-positive-cash-flow/20461/
" string(53) "/publication/greggs-passes-the-scorch-test/22252/
" string(37) "/publication/growing-again/16195/
" string(61) "/publication/growing-exposure-to-the-fintech-space/24001/
" string(37) "/publication/growing-pains/23704/
" string(66) "/publication/growth-accelerating-in-q3-forecasts-raised/22907/
" string(69) "/publication/growth-and-income-from-a-contrarian-portfolio/23056/
" string(60) "/publication/growth-moderates-but-strategy-on-plan/21052
" string(61) "/publication/growth-moderates-but-strategy-on-plan/21052/
" string(66) "/publication/growth-strategy-drives-strong-fy19-results/24483/
" string(49) "/publication/growth-strategy-paying-off/24161
" string(60) "/publication/guidance-maintained-with-strong-q318/22660/
" string(63) "/publication/guidance-sinks-on-quality-control-issue/24915/
" string(69) "/publication/gwa-farm-in-accelerates-resource-monetisation/22217/
" string(50) "/publication/healthy-cash-flows-in-the-future/
" string(52) "/publication/high-grade-gold-in-greenland/22286/
" string(54) "/publication/high-growth-german-property-investor/
" string(65) "/publication/higher-mtd-new-collaboration-for-gdc-0084/24451/
" string(68) "/publication/ibn-yunus-1-de-risking-abu-madi-baltim-trend/20825/
" string(64) "/publication/impala-readout-ends-monotherapy-strategy/24982/
" string(64) "/publication/improved-returns-but-discount-has-widened/21729
" string(65) "/publication/improved-returns-but-discount-has-widened/21729/
" string(60) "/publication/in-a-cell-and-gene-therapy-sweet-spot/24313
" string(66) "/publication/in-licensing-deal-for-cf33-oncolytic-virus/24609/
" string(47) "/publication/in-line-year-end-update/23362/
" string(63) "/publication/income-and-growth-from-credit-portfolio/19227/
" string(67) "/publication/increased-marketing-to-drive-revenue-growth/23973/
" string(60) "/publication/industry-backdrop-remains-favourable/23429/
" string(72) "/publication/infrastructure-upgrade-offers-growth-opportunity/24080/
" string(129) "/publication/inm-755-getting-closer-to-the-clinic/25156/?fbclid=IwAR0oJFVMABtPMzO1KtQiMAJpZPnSA-GuQQTHTAaQ7-pfe1x8GafpvCUEx_Q
" string(47) "/publication/innovating-cannabinoids/21293/
" string(57) "/publication/innovative-approach-to-de-risking/22514/
" string(55) "/publication/innovative-clinical-diagnostics/18305/
" string(68) "/publication/interim-data-from-phase-iia-etheral-ad-study/24641/
" string(60) "/publication/interim-phase-ii-clepsidra-results-at-esmo/
" string(67) "/publication/interims-reflect-a-more-predictable-business/24490
" string(58) "/publication/international-drives-revenue-growth/7138/
" string(47) "/publication/investing-for-future-growth-2/
" string(44) "/publication/investing-for-growth/20006/
" string(43) "/publication/investing-in-evofem/23948/
" string(55) "/publication/italian-software-treasure-chest/16246/
" string(50) "/publication/its-not-over-till-its-over/24412/
" string(71) "/publication/jupiter-sale-funds-buyback-and-special-dividend/24587/
" string(64) "/publication/kicking-the-hornets-nest-of-immunoncology/21292
" string(31) "/publication/kunning/23816/
" string(67) "/publication/large-opportunity-in-healthcare-recruitment/21859/
" string(62) "/publication/leading-european-data-processing-group/18950/
" string(52) "/publication/leaving-clinical-risk-behind/18472/
" string(55) "/publication/less-dividend-equals-more-deals/16854/
" string(48) "/publication/library-valuation-uplift/22138/
" string(39) "/publication/life-in-the-fast-lane/
" string(45) "/publication/life-in-the-fast-lane/19072/
" string(57) "/publication/lincoln-crestal-positive-flow-test/25043
" string(67) "/publication/long-established-asian-small-cap-specialist/20160/
" string(67) "/publication/looking-ahead-with-differentiated-portfolio/20420/
" string(39) "/publication/looking-to-2017/17773/
" string(69) "/publication/looking-towards-pivotal-cavatak-combo-studies/20031/
" string(63) "/publication/low-volumes-induce-quarterly-volatility/24121/
" string(39) "/publication/lupus-signature/16790/
" string(38) "/publication/maiden-profits/17373/
" string(55) "/publication/major-orders-and-ma-fuel-growth/24974/
" string(65) "/publication/making-good-progress-on-technology-roadmap/24973
" string(41) "/publication/making-music-easy/16215/
" string(42) "/publication/mammalian-movement/24028/
" string(37) "/publication/marching-on-up/23961
" string(58) "/publication/market-heavily-discounting-sea-lion/23224
" string(44) "/publication/market-information-2/23640/
" string(55) "/publication/market-to-enable-further-growth/23953/
" string(70) "/publication/market-volatility-providing-more-opportunities/24421/
" string(54) "/publication/maturing-epigenetics-portfolio/18638/
" string(67) "/publication/mbe-deliveries-offset-lower-evaporator-sales/24800
" string(60) "/publication/metals-price-moves-de-risk-valuation/24854/
" string(49) "/publication/mgn1703-remains-the-focus/15535/
" string(54) "/publication/michael-bolinder-to-become-ceo/24635/
" string(57) "/publication/mitochondrial-medicine-specialist/19139/
" string(69) "/publication/more-defensive-in-response-to-macro-headwinds/22930/
" string(55) "/publication/multi-manager-global-investment/16593/
" string(54) "/publication/multiple-studies-moving-forward/24386
" string(37) "/publication/music-therapy/20156/
" string(57) "/publication/nda-resubmission-before-month-end/24978/
" string(66) "/publication/new-ceo-as-company-moves-toward-late-stage/25059/
" string(55) "/publication/new-ceo-to-pilot-growth-strategy/23770
" string(56) "/publication/new-ceo-to-pilot-growth-strategy/23770/
" string(53) "/publication/new-e1bn-buyout-fund-launched/16932/
" string(53) "/publication/new-experienced-lead-managers/23569/
" string(52) "/publication/new-frontiers-in-epigenetics/15972/
" string(63) "/publication/new-generation-of-allergy-immunotherapy/21203/
" string(61) "/publication/new-impetus-for-injectables-franchise/17263/
" string(52) "/publication/new-indications-for-gdc-0084/22441/
" string(44) "/publication/new-investments-ahead/8502/
" string(54) "/publication/new-microsoft-ai-collaboration/21210/
" string(67) "/publication/new-partner-strong-organic-growth-prospects/23006/
" string(62) "/publication/new-world-of-integrated-smart-surfaces/20772/
" string(71) "/publication/next-generation-of-dna-damage-repair-inhibitors/25072/
" string(38) "/publication/next-up-rd-day/22281/
" string(62) "/publication/nidanilimab-transitioning-to-phase-iia/23062/
" string(58) "/publication/no-surprises-in-fy18-annual-report/24187/
" string(75) "/publication/novartis-endocyte-deal-illustrates-upside-potential/22474/
" string(68) "/publication/nu-q-lung-cancer-test-development-accelerates/24872
" string(64) "/publication/odor-no-more-and-blest-almost-break-even/24979/
" string(66) "/publication/on-a-roll-unscheduled-vegan-driven-upgrade/23456/
" string(55) "/publication/on-track-to-reach-profitability/24749/
" string(73) "/publication/oncology-product-portfolio-to-drive-future-growth/21555/
" string(61) "/publication/one-stop-shop-for-ex-uk-equity-income/21657/
" string(55) "/publication/operating-profitability-achieved/24259
" string(54) "/publication/opic-funding-a-key-endorsement/23514/
" string(63) "/publication/optimised-hunting-for-the-hidden-killer/24074/
" string(67) "/publication/order-book-boosted-by-numerous-large-orders/24296/
" string(60) "/publication/orders-support-h2-momentum-into-fy20/24067/
" string(60) "/publication/outperforming-in-an-uncertain-market/22429/
" string(65) "/publication/outsourcing-and-e-commerce-boosting-growth/7698/
" string(46) "/publication/outstanding-first-half/20921/
" string(73) "/publication/paediatric-aki-application-pulled-q4-resubmission/24653/
" string(74) "/publication/paediatric-ngal-test-submitted-with-breakthrough-2/24199/
" string(69) "/publication/participations-and-fees-assisting-h119-results/24939
" string(70) "/publication/participations-and-fees-assisting-h119-results/24939/
" string(68) "/publication/patch-reordering-and-an-emerging-us-strategy/24901/
" string(52) "/publication/phase-ii-xanadu-trial-results/24101
" string(65) "/publication/phase-iib-trial-of-apc-activator-underway/15589/
" string(74) "/publication/phase-iii-for-universal-flu-vaccine-starts-in-2018/20175/
" string(54) "/publication/pillars-of-growth-standing-firm/25106
" string(47) "/publication/pixium-appoints-new-ceo/24068/
" string(69) "/publication/plenty-of-attractive-investment-opportunities/23852/
" string(56) "/publication/portfolio-transition-in-progress/24902/
" string(70) "/publication/positioned-to-perform-in-challenging-conditions/8334/
" string(64) "/publication/positive-income-driven-returns-continuing/PCTN/
" string(59) "/publication/positive-momentum-continued-in-h119/24791/
" string(61) "/publication/positive-momentum-on-trading-and-cash/17832/
" string(69) "/publication/positive-reinvestment-of-residential-proceeds/23068/
" string(62) "/publication/positive-trading-and-dividend-increase/24302/
" string(58) "/publication/positive-trading-update-to-november/23057
" string(65) "/publication/positive-underlying-nav-progress-continues/7456/
" string(57) "/publication/post-acquisition-valuation-update/23918/
" string(66) "/publication/power-gas-the-growth-engine-of-mytilineos-2/24661
" string(36) "/publication/power-growth/24075/
" string(65) "/publication/preparing-for-dnv3837-phase-ii-trial-start/24007
" string(71) "/publication/preserving-capital-with-less-correlated-returns/23319/
" string(64) "/publication/price-beating-products-for-major-markets/17462/
" string(67) "/publication/pro-forma-figures-10-5-eps-accretion-in-fy20/24426
" string(58) "/publication/product-innovation-supports-order-growth/
" string(60) "/publication/product-quality-and-management-depth/17667/
" string(42) "/publication/progress-continues/20335/
" string(71) "/publication/progress-in-heart-failure-and-controlled-release/24401
" string(51) "/publication/progress-in-ngal-test-sales/23521/
" string(48) "/publication/progress-on-all-fronts-2/21816/
" string(63) "/publication/progress-towards-independent-businesses/24227/
" string(69) "/publication/progress-with-ongoing-trials-and-future-plans/20848/
" string(63) "/publication/promising-eye-d-vs-101-phase-i-iia-data/19360/
" string(51) "/publication/prostate-programmes-boosted/23842/
" string(62) "/publication/ptsd-awareness-day-and-earnings-update/17611/
" string(63) "/publication/purchase-of-3ms-ballistic-protection-business/
" string(68) "/publication/purchase-of-3ms-ballistic-protection-business/24805
" string(70) "/publication/q1-growth-trend-exceeds-our-expectations-again/24295/
" string(36) "/publication/q119-results/24160/
" string(34) "/publication/q3-results/17524/
" string(56) "/publication/q3-trading-statement-stills-crazy/7402/
" string(59) "/publication/ramping-up-to-230mmscfd-by-end-2018/20158/
" string(59) "/publication/rapid-acceleration-in-the-us-market/23912/
" string(65) "/publication/rd-progress-triggers-milestone-payment-windfall/
" string(40) "/publication/ready-for-growth/24223/
" string(63) "/publication/ready-to-accelerate-loan-book-expansion/24400/
" string(39) "/publication/realising-value/22350/
" string(47) "/publication/reasons-to-be-optimistic/21684
" string(69) "/publication/recent-deals-enable-greater-focus-on-the-core/15782/
" string(56) "/publication/recommended-cash-offer-from-rank/24305/
" string(49) "/publication/record-production-achieved/25064
" string(59) "/publication/record-revenues-despite-us-shutdown/21856/
" string(50) "/publication/recurring-revenue-jumps-48/23797/
" string(64) "/publication/regaining-adasuve-rights-amid-strategic-review/
" string(63) "/publication/resilience-over-the-peak-trading-period/23169/
" string(54) "/publication/restoring-power-and-cash-flow-growth/
" string(55) "/publication/results-exceed-strategy-evolves/19936/
" string(61) "/publication/revenues-more-than-doubled-during-fy18/23600
" string(52) "/publication/rewards-for-keeping-the-faith/22994
" string(46) "/publication/rhb-104-data-look-good/21740/
" string(35) "/publication/right-focus/18278/
" string(51) "/publication/rights-success-fuels-growth/24761/
" string(56) "/publication/roche-returns-rights-on-ory-1001/19287/
" string(66) "/publication/sale-of-hawkeye-360-returns-to-shareholders/25140
" string(47) "/publication/sandfire-to-acquire-mod/24486/
" string(63) "/publication/santen-a-global-player-in-ophthalmology/24491/
" string(66) "/publication/second-half-strength-supports-the-strategy/17543/
" string(72) "/publication/second-half-trading-as-expected-with-higher-cash/22031/
" string(70) "/publication/securing-lanstead-tulu-kapi-financing-underway/18003/
" string(61) "/publication/seeking-gains-from-regulatory-changes/23314/
" string(65) "/publication/seeking-opportunities-in-leveraged-credit/20625/
" string(68) "/publication/sel120-to-enter-clinical-development-in-2019/23182/
" string(42) "/publication/sensing-the-future/22672/
" string(65) "/publication/services-and-oncology-businesses-to-split/23878/
" string(61) "/publication/setting-the-scene-for-profit-recovery/25144/
" string(55) "/publication/seven-months-seven-acquisitions/24881/
" string(67) "/publication/sharper-focus-on-quality-under-new-managers/24544/
" string(51) "/publication/shining-a-light-in-eye-care/17274/
" string(34) "/publication/skyepharma/16001/
" string(53) "/publication/small-but-potential-to-disrupt/7080/
" string(61) "/publication/solid-foundations-with-potential-for-growth/
" string(50) "/publication/solid-growth-in-new-orders/24924/
" string(37) "/publication/stable-outlook/24999
" string(35) "/publication/steady-progress-4/
" string(41) "/publication/steady-progress-6/24687/
" string(67) "/publication/steady-progress-in-unfavourable-environment/25097/
" string(50) "/publication/steady-progress-with-core-assets/
" string(55) "/publication/step-up-in-relative-performance/24540/
" string(59) "/publication/stonepeak-increases-its-involvement/19195/
" string(75) "/publication/strategic-deal-signed-with-enterprise-cloud-partner/24607/
" string(43) "/publication/strategy-paying-off/16229/
" string(62) "/publication/strong-delivery-with-further-potential/18648/
" string(39) "/publication/strong-delivery/24476/
" string(70) "/publication/strong-ebitda-driven-by-vlts-and-cost-controls/24350/
" string(47) "/publication/strong-finish-to-fy18-3/23145/
" string(65) "/publication/strong-fy18-progress-and-positive-outlook/21974/
" string(48) "/publication/strong-growth-continuing/24209/
" string(55) "/publication/strong-long-term-capital-growth/21880/
" string(70) "/publication/strong-organic-growth-puts-ltg-ahead-of-target/19568/
" string(58) "/publication/strong-performance-delivers-growth/23008/
" string(38) "/publication/strong-pipeline/24151
" string(61) "/publication/strong-results-with-improving-outlook/20567/
" string(70) "/publication/strong-returns-from-established-asia-specialist/19393
" string(69) "/publication/stronger-nav-returns-but-discount-remains-wide/24842
" string(91) "/publication/stronger-nav-returns-but-discount-remains-wide/24842 ahh - also in Header/
" string(58) "/publication/structural-and-cyclical-locomotion/19575/
" string(61) "/publication/subdued-markets-but-progress-expected/15385/
" string(60) "/publication/successful-merger-and-strong-outlook/24923/
" string(66) "/publication/support-for-abeta-theory-from-biogen-eisai/22492/
" string(60) "/publication/surfing-the-next-wave-of-biosimilars/18351/
" string(48) "/publication/suspension-of-estimates-6/24993
" string(49) "/publication/suspension-of-estimates-7/25117/
" string(59) "/publication/sustained-high-transaction-activity/24293/
" string(60) "/publication/taking-advantage-of-the-cannabis-boom/24288
" string(36) "/publication/taking-shape/22284/
" string(60) "/publication/targeting-acquisitions-and-contracts/18324/
" string(59) "/publication/tax-stamp-deals-underpin-pat-growth/23837/
" string(45) "/publication/tempering-near-term-outlook/
" string(43) "/publication/termination-of-coverage-9/
" string(69) "/publication/the-benefits-of-partnerships-and-cost-control/23572/
" string(63) "/publication/the-land-of-opportunity-awaits-accrufer/24799/
" string(43) "/publication/the-leader-in-lag-3/16772/
" string(60) "/publication/the-next-generation-of-cardiac-drugs/17595/
" string(39) "/publication/time-to-reflect/23059/
" string(54) "/publication/trading-ahead-of-expectations-2/25058
" string(61) "/publication/trading-update-and-library-revaluation/25142
" string(48) "/publication/transformation-under-way/16235/
" string(40) "/publication/treating-vertigo/22494/
" string(70) "/publication/trinidad-new-energy-to-low-cost-low-risk-region/6774/
" string(32) "/publication/tuning-up/19535
" string(59) "/publication/turnaround-success-but-supply-risks-ahead/
" string(57) "/publication/underwritten-open-offer-announced/24165/
" string(72) "/publication/unloved-small-caps-offer-long-term-opportunities/23941/
" string(53) "/publication/us-continues-to-be-the-driver/24818/
" string(70) "/publication/us-customer-supports-substantial-revenue-growth/23882
" string(59) "/publication/validation-achieved-growth-expected/21055/
" string(67) "/publication/valuation-remains-attractive-after-strong-q1/24358
" string(67) "/publication/value-enhancing-deal-at-a-modest-0-8x-sales/18520/
" string(49) "/publication/value-property-specialist/19489/
" string(46) "/publication/venezuela-costs-dearly/24336/
" string(60) "/publication/visible-income-and-growth-potential-2/23410
" string(61) "/publication/visible-income-and-growth-potential-2/23410/
" string(69) "/publication/well-placed-for-chinas-coming-adas-revolution/19808/
" string(74) "/publication/year-end-update-highlights-transaction-potential-2/24196/
" string(56) "/publication/year-to-date-trading-as-expected/24446/
" string(142) "/search?q=cache:oIaGH7-1zpsJ:https://www.edisongroup.com/publication/positive-momentum-continued-in-h119/24791/+&cd=57&hl=en&ct=clnk&gl=us
" string(286) "/translate?to=fr&csId=517f1945-3880-4ce4-ac9c-f959f3eca027&usId=dbade561-1a46-42e6-b14c-2eb37ef16916&ref=SERP&refd=www.translatetheweb.com&dl=fr&dt=2019/10/3 18:50&h=X5EegU3K9_udQugj6qiGw_qxq2Uyv7kp&a=https://www.edisongroup.com/publication/weak-evaporator-market-affects-h119/25218
" string(295) "/translate_c?depth=1&hl=de&prev=search&rurl=translate.google.com&sl=en&sp=nmt4&u=https://www.edisongroup.com/publication/xadago-slows-evenamide-lags-but-stars-ahead/25236&xid=17259,15700022,15700186,15700191,15700256,15700259,15700262,15700265,15700271&usg=ALkJrhjWLgLH-3GHraZFfA0jKtU8eNp4PA
" string(300) "/translate_c?depth=1&hl=de&rurl=translate.google.com&sl=auto&sp=nmt4&tl=de&u=https://www.edisongroup.com/publication/xadago-slows-evenamide-lags-but-stars-ahead/25236&xid=17259,15700021,15700043,15700186,15700191,15700256,15700259,15700262,15700265,15700271&usg=ALkJrhhc5m2UC6KP5yrZVKovLoFdcei0yQ
" string(287) "/translate_c?depth=1&hl=fr&prev=search&rurl=translate.google.com&sl=en&sp=nmt4&u=https://www.edisongroup.com/publication/boosting-organic-growth-with-us-acquisition/24804/&xid=25657,15700021,15700186,15700191,15700256,15700259,15700262,15700265&usg=ALkJrhiJ8BpaMPKwwFrau6qrp9rvQ6m7qA
"